AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Xencor, Inc.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG0026ZG4X9
25.18▼ 0.66 (-2.55%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
25.84
Day's Range
24.42 – 25.81
52-Week Range
10.38 – 30.61
Volume
1.5M
Avg Volume
1.4M
Share Statistics
Shares Outstanding
Employees
260
Exchange
XNAS
Listed
2013-12-03
Share count as of July 31, 2026

Xencor, Inc. (XNCR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Xencor, Inc. (XNCR)
What is Xencor, Inc.'s Market Cap?
Xencor, Inc.'s Market Cap is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s Enterprise Value?
Xencor, Inc.'s Enterprise Value is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s Price / Sales?
Xencor, Inc.'s Price / Sales is 17.8×, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s EV / Revenue?
Xencor, Inc.'s EV / Revenue is 18.4×, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s EV / EBITDA?
Xencor, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s Revenue (TTM)?
Xencor, Inc.'s Revenue (TTM) is $105.0M, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s Net Income (TTM)?
Xencor, Inc.'s Net Income (TTM) is -$163.3M, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s EBITDA?
Xencor, Inc.'s EBITDA is -$205.9M, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s Diluted EPS (TTM)?
Xencor, Inc.'s Diluted EPS (TTM) is -2.20, based on as-reported figures from SEC (XBRL) filings.
What is Xencor, Inc.'s EBITDA Margin?
Xencor, Inc.'s EBITDA Margin is -196.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · XNCRAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Collaborations, milestones, and royalties
YoY growth+17.5%-86.2%-46.5%+18.0%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue172.4%1824.1%289.9%326.3%
Operating loss
% of revenue-72.4%-1724.1%-189.9%-226.3%
Other income (expense):
Interest income
Interest expense
Gains (losses) on equity securities, net
Asset impairment charges
Other, net
Total other income (expense)
Loss before income tax expense (benefit) and noncontrolling interest
Income tax (benefit) expense
Net loss including noncontrolling interest
% of revenue-42.4%-2854.7%-23.6%-28.7%
Net loss attributable to noncontrolling interest
Net loss attributable to Xencor, Inc.
% of revenue-42.4%-2854.7%-23.6%-28.7%
Net loss per share attributable to Xencor, Inc. - basic (in dollars per share)
Net loss per share attributable to Xencor, Inc. - diluted (in dollars per share)